Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Axe Compute Inc. (AGPU : NSDQ)

• Company Description    Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. Number of Employees: 14

• Price / Volume Information    Yesterday's Closing Price: $7.10 Daily Weekly Monthly 20 Day Moving Average: 10,118,435 shares Shares Outstanding: 5.54 (millions) Market Capitalization: $39.33 (millions) Beta: 1.44 52 Week High: $19.19 52 Week Low: $1.03 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 379.73% 337.13% 12 Week 182.87% 177.32% Year To Date -0.70% -4.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 91 43RD STREET SUITE 110 - PITTSBURGH,PA 15201 USA ph: 412-432-1500 fax: - ir@axecompute.com https://axecompute.com

• General Corporate Information    Officers Christopher Miglino - Chief Executive Officer Josh Blacher - Chief Financial Officer Chuck Nuzum - Director Thorsten Dirks - Director Theodore Zhu - Director Peer Information Axe Compute Inc. (ITRJ) Axe Compute Inc. (BRLI.) Axe Compute Inc. (GOGY) Axe Compute Inc. (PSTX.) Axe Compute Inc. (ELGXQ) Axe Compute Inc. (CAH) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED/DENTAL-SUPP Sector: Medical CUSIP: 74039M408 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 05/13/26 Share - Related Items Shares Outstanding: 5.54 Most Recent Split Date: 9.00 (0.07:1) Beta: 1.44 Market Capitalization: $39.33 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.61 Price/Cash Flow: - Price / Sales: 312.95 EPS Growth vs. Year Ago Period: 16.25% vs. Previous Quarter: -37.04% Sales Growth vs. Year Ago Period: -1.34% vs. Previous Quarter: 116.85% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - -970.41 09/30/25 - -220.96 Current Ratio 03/31/26 - - 12/31/25 - 10.02 09/30/25 - 0.01 Quick Ratio 03/31/26 - - 12/31/25 - 10.02 09/30/25 - 0.01 Operating Margin 03/31/26 - - 12/31/25 - -126,110.44 09/30/25 - -7,646.75 Net Margin 03/31/26 - - 12/31/25 - -185,476.72 09/30/25 - -67,043.21 Pre-Tax Margin 03/31/26 - - 12/31/25 - -185,860.92 09/30/25 - -66,764.98 Book Value 03/31/26 - - 12/31/25 - 11.69 09/30/25 - -18.39 Inventory Turnover 03/31/26 - - 12/31/25 - 2.30 09/30/25 - 3.24 Debt-to-Equity 03/31/26 - - 12/31/25 - 0.00 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - 0.00 09/30/25 - -

Powered by Zacks Investment Research ©